Contract facts
FederalNo full NAICS 541714 intel page yet. Browse NAICS intelligence
To Conduct a Clinical Trial to Assess the Safety, Immunogenicity, Antigen Dose, of Matrix-M Adjuvant in Combination wit… is a federal award for Barda - Aspr / Daappo / Barda Dcma held by Sanofi Pasteur Inc. Estimated value $24.9M ($24.9M obligated). Current period of performance ends Sep 4, 2028. Place of performance: SWIFTWATER PA. Related solicitation RTOR #: 2025-00015.
To conduct a clinical trial to assess the safety, immunogenicity, antigen dose, of matrix-m adjuvant in combination with u.s. domestically manufactured, egg-based a/astrakhan/3212/2020 (h5n8) influenza virus vaccine in healthy adults and older adults
Recompete timing
PublicCurrent PoP ends Sep 4, 2028 (688 days remaining). Agencies typically plan 12–18 months ahead — capture window opens around Mar 4, 2027.
Want the durability read on 75A50125F61012? One Pursuit Analysis, $500, inside 48 business hours.
- 48 business hours
- $500
- Credits toward the Pack
Incumbent footprint
Public recordSanofi Pasteur Inc — $3.7B obligated across 396 awards (firm-wide, all agencies) · lead buyer Department of Health and Human Services (HHS).
Related awards
Same parent · incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract 75A50125F61012?
75A50125F61012 (Conduct a clinical trial to assess) is a Barda - Aspr / Daappo / Barda Dcma award with a potential value of $24.9M, currently held by Sanofi Pasteur Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
Which office awarded 75A50125F61012?
Barda - Aspr / Daappo / Barda Dcma awarded 75A50125F61012 to Sanofi Pasteur Inc (potential $24.9M).
Who is the incumbent on 75A50125F61012?
Sanofi Pasteur Inc is the incumbent with $3.7B across 396 related awards in SCOUT’s public footprint. The current period of performance ends Sep 4, 2028.
When does Sanofi Pasteur Inc’s 75A50125F61012 come up for recompete?
SCOUT tracks a period-of-performance end of Sep 4, 2028. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Want the durability read on 75A50125F61012? One Pursuit Analysis, $500, inside 48 business hours.
One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.
No card · under a minute · then the Sprint menu
Use SCOUT in your AI client — $29/moClassify + search inside Claude, ChatGPT, Cursor
Compare plansData: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.